Roche launches MabThera in Japan

Roche (SWX:ROCZ) launched MabThera to treat non-Hodgkin's lymphoma (NHL) in Japan. MabThera was discovered by Idec (IDPH) and is marketed in the U.S. by IDPH and partner Genentech (DNA) under the name...